In a retrospective ongoing study, the incidence of nosocomial candidemia among patients (pts) admitted to a tertiary-care teaching hospital (bed capacity 2400; 78 beds for intensive care units, ICUs) was evaluated together with causative pathogens, potential risk factors, antifungal treatment, and crude mortality. During the primary study period (November 1991---October 1994) there were 136 episodes of candidemia occurring in 136 pts (median age 62 years, range 4--96). The overall incidence of candidemia was 11.3 episodes per 10 000 hospital admissions. The underlying diseases were the following: solid or hematological malignancies (43 pts), major abdominal surgery (30 pts), cardiovascular diseases (18 pts), trauma (17 pts), other diseases (28 pts). At the onset of candidemia 67 pts (49%) were located in ICUs, 48 and 21 pts respectively in surgical and medical wards. *C. albicans* (83 strains) accounted for 53% of all blood culture Candida isolates. Fifty-three pts (39%) received adequate antifungal treatment: 16 pts amphotericin-B and 37 pts fluconazole. The overall crude mortality was 54%. The number of positive fungal blood cultures (1 culture versus \>1 culture) did not influence crude mortality (54% versus 63%). In addition, the mortality of pts infected by *C. albicans* (55%) was similar to that of pts infected by *C. non-albicans* species (45%). The mortality of pts located in ICUs (79%) was significantly higher (*P* \< 0.001) than that of pts in surgical (29%) and medical wards (33%). Finally, the mortality of pts who did not receive adequate antifungal therapy (70%) was significantly higher (*P* \< 0.001) than that of treated pts (30%). In conclusion, the incidence of nosocomial candidemia was high during the primary phase of the study; most of our pts with candidemia had severe underlying diseases and were hospitalized in ICUs. The number of fungal positive blood cultures did not influence the crude mortality, confirming that a single bood culture shuld not be dismissed as benign transient candidemia. On the contrary, about two-third of our pts did not receive an adequate antifungal treatment and the majority of them died.
